1. The need for screening, assessment, and treatment for cognitive dysfunction in multiple sclerosis;Foley;Int J Mult Scler Care,2012
2. Improvement of neuropsychological function in cognitively impaired multiple sclerosis patients treated with natalizumab;Edwards;Int J Mult Scler Care,2012
3. Rahn KA, Watkins CC, Alt J, et al. Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc Natl Acad Sci U S A Early Edition. P 1-6
4. Krupp LB, Serafin DJ. Multiple Sclerosis-associated fatigue. In: Cohen JA, Rudick RA, editors. Multiple Sclerosis Therapeutics. Cambridge University Press; 2011: 654-661